Page 33 - CSIR-IGIB Annual Report 2020-21
P. 33

Why  do  vitiligo patients rarely develop skin
                cancer
                Vitiligo occurs because  of the loss  of  cells
                (melanocytes) responsible for producing
                melanin (the  pigment that gives skin  its
                characteristic color) resulting in  the  affected
                skin appearing  milky white. The  presence of
                melanin pigment acts  as a barrier to the
                harmful, cancer-inducing, sun’s rays [ultraviolet
                (UV) radiation]. Surprisingly, despite the loss of
                melanin, people with vitiligo rarely develop skin
                cancers. We therefore investigated the
                molecular   mechanisms     underlying  this
                conundrum.  We obtained small skin samples
                from affected as well as the unaffected skin
                from five people who had vitiligo and extracted
                small pieces of  RNA  known as microRNAs
                (miRNAs) from them.  One  miRNA  –  called
                miRNA-211 was found to be present in very low
                quantities in vitiligo  compared with the         Overall, this study found that a novel molecular
                unaffected skin. We found that  this miRNA        basis for the protection of vitiligo skin from sun-
                could bind  to another  type of  RNA called       induced damage  is MALAT1-  miR-211-SIRT1
                messenger RNA (mRNA) of the SIRT1 gene and        signaling axis.
                prevent it from making  the sirtuin1  (SIRT1)
                protein. Lower levels of miRNA-211 in vitiligo    Delayed wound healing in vitiligo: Role  of
                skin  meant less ‘stop signals’, leading to an    miRNAs
                increased expression of the SIRT1 protein.  To    Cutaneous wound healing requires a temporally
                understand whether  the increased SIRT1           coordinated     communication     between
                protein  could protect  the skin  cells from sun-  keratinocytes,  fibroblasts,  and  immune cells.
                induced damage, we treated keratinocytes (a       However, the role of melanocytes, the pigment-
                type of skin cell) with a chemical that activated   synthesizing  cells in the epidermis,  remains
                SIRT1 and  we exposed these  cells to UV          poorly explored. Thus, vitiligo, characterized by
                radiation, mimicking sunlight exposure to the     the selective loss of melanocytes, provided the
                skin. Exposure of these treated keratinocytes to   perfect opportunity to  dissect  their role  in
                UV radiation showed a significant reduction in    influencing the kinetics of wound healing. The
                signs of DNA damage (cyclobutane pyrimidine       role of miRNAs is well established in skin
                dimers) as compared with cells with usual SIRT1   development and pathology, including their
                levels. Finally, we found that MALAT1, a long     contribution in regulating wound healing. Thus,
                non-protein coding RNA molecule,  was  highly     we hypothesized that the loss of melanocytes
                expressed in vitiligo skin, and that it could bind   and/or its downstream effect(s) could be
                to miRNA-211 making it unavailable to bind to     causing a dysregulation of miRNAs, leading to a
                SIRT1 mRNA and therefore leading to increased     delay in re-epithelialization of lesional skin
                SIRT1 protein expression, which protected the     reported previously by our group.  We
                patient’s skin.                                   performed a genome-wide miRnome  of  non-
                                                                  lesional (NL) and lesional (L) skin on day1 (basal
                                                                  level) as well as on day 14 (re-epithelialization
                                                                  phase) and analysed the differentially expressed





               Annual Report 2020-21                                                                       30
   28   29   30   31   32   33   34   35   36   37   38